Great Basin Scientific to Demonstrate its Diagnostics Platform at AMP 2016
Nov 10, 2016 12:01 pm UTC| Business
SALT LAKE CITY, Nov. 10, 2016 -- Great Basin Scientific, Inc. (OTCQB:GBSN), a molecular diagnostics company, will demonstrate its molecular diagnostics platform at the Association for Molecular Pathology (AMP) 2016...
Great Basin Scientific to Demonstrate its Diagnostics Platform at AMP 2016
Nov 10, 2016 12:01 pm UTC| Business
SALT LAKE CITY, Nov. 10, 2016 -- Great Basin Scientific, Inc. (OTCQB:GBSN), a molecular diagnostics company, will demonstrate its molecular diagnostics platform at the Association for Molecular Pathology (AMP) 2016...
BlueLinx Announces Third-Quarter Results
Nov 10, 2016 12:01 pm UTC| Business
– Net income of $15.0 million; highest quarter net income since 2004 –– Diluted earnings per share of $1.68 –– Debt principal reduction of $87.2 million from Q3 2015 – ATLANTA, Nov. 10, 2016 -- BlueLinx Holdings Inc....
BlueLinx Announces Third-Quarter Results
Nov 10, 2016 12:01 pm UTC| Business
– Net income of $15.0 million; highest quarter net income since 2004 –– Diluted earnings per share of $1.68 –– Debt principal reduction of $87.2 million from Q3 2015 – ATLANTA, Nov. 10, 2016 -- BlueLinx Holdings Inc....
NeuroDerm Announces Third Quarter 2016 Financial Results
Nov 10, 2016 12:01 pm UTC| Business
REHOVOT, Israel, Nov. 10, 2016 -- NeuroDerm Ltd. (Nasdaq:NDRM), a clinical stage pharmaceutical company developing drugs for central nervous system (CNS) diseases, today announced financial results for the third quarter...
ZIOPHARM to Present at the Jefferies 2016 London Healthcare Conference
Nov 10, 2016 12:01 pm UTC| Business
BOSTON, Nov. 10, 2016 -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP) today announced that Laurence Cooper, M.D., Ph.D., Chief Executive Officer, will present at the Jefferies 2016 London Healthcare Conference on Thursday,...
ZIOPHARM to Present at the Jefferies 2016 London Healthcare Conference
Nov 10, 2016 12:01 pm UTC| Business
BOSTON, Nov. 10, 2016 -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP) today announced that Laurence Cooper, M.D., Ph.D., Chief Executive Officer, will present at the Jefferies 2016 London Healthcare Conference on Thursday,...